Standout Papers

Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in ca... 2017 2026 2020 2023 326
  1. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment (2017)
    Hitisha Patel, Teeru Bihani Pharmacology & Therapeutics

Immediate Impact

1 from Science/Nature 69 standout
Sub-graph 1 of 23

Citing Papers

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence
2024 Standout
2 intermediate papers

Works of Hitisha Patel being referenced

Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
2017 Standout
Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models
2017

Author Peers

Author Last Decade Papers Cites
Hitisha Patel 288 253 245 13 625
Shalini Murthy 184 126 175 14 616
Jennifer L. Ariazi 284 50 147 10 613
Catherine Jones 406 95 258 13 687
Catherine G.N. Sharma 229 61 162 12 606
Frederik Holst 238 120 245 23 718
Elisavet Paplomata 50 155 300 14 683
Diana C. West 82 56 142 10 513
Yves Communal 140 124 148 23 659
Birgit Olsson 143 143 269 13 718
Benjamin P. Haynes 171 233 135 14 521

All Works

Loading papers...

Rankless by CCL
2026